Cannabis sector ETFs

Last week, which ended on May 25, cannabis sector ETFs slipped into negative territory sequentially, with the Horizons Marijuana Life Sciences ETF (HMMJ) closing ~1% lower than the closing on May 18. The ETFMG Alternative Harvest ETF (MJ) fell ~1.7%, and the Horizons Emerging Marijuana Growers Index ETF (HMJR) fell ~1.7%. The Evolve Marijuana ETF (SEED) fell 1.4%.

Let’s look now at the performances of some of the major cannabis stocks that are part of these ETFs.

Cannabis Stock Returns for the Week Ended May 25 2018-05-27

Cannabis stocks

Last week, Emerald Health Therapeutics (EMHTF) emerged as the lowest performer with its stock falling 10.4% to 4.20 Canadian dollars. It was followed by Cronos Group (CRON), which fell 3.1% to 7.80 Canadian dollars, and Aphria (APHQF), which fell 2.9% to 11.90 Canadian dollars. Canopy Growth (WEED), one of the major cannabis players, ended up in negative territory, declining 2.9% to 35 Canadian dollars, while CannTrust Holdings (CNTTF) was next with its stock falling 2% to 8.60 Canadian dollars. MedReleaf fell slightly by 37 basis points to 24.50 Canadian dollars.

Among the stocks that gained last week were Supreme Cannabis, which rose 4.1% to 1.80 Canadian dollars, followed by OrganiGram Holdings, which gained 1.7% to 4.90 Canadian dollars. Hydropothecary was also one of the gainers, rising 1.4% to 5.20 Canadian dollars, followed by Aurora Cannabis (ACB) (ACBFF), which rose 1.3% to 8 Canadian dollars.

YTD performance

YTD (year-to-date), seven of the ten companies in the above chart are still in negative territory. Aphria (APHQF) emerged as the lowest performer, falling 41%, followed by Supreme Cannabis with a 34% decline and Aurora Cannabis with a 32% decline.

Hydropothecary emerged as the top gainer, rising 15.7%. It was followed by OrganiGram, which rose 8.4%, and Canopy Growth, which rose 8.1%.